Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery1, Mike Briley2 1Imperial College School of Medicine, London, England, UK; 2NeuroBiz Consulting and Communication, Castres, FranceMilnacipran: recent findings in depressionMilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) which was first approved for the treatm...
Saved in:
Main Authors: | Stuart Montgomery, Mike Briley |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/b865ead338664fdc9c611ed1c9f0f16d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Milnacipran: recent findings in depression
by: Guest editors: Stuart Montgomery (London, et al.
Published: (2010) -
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
by: Peter Hofmann
Published: (2010) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
by: Alla Avedisova, et al.
Published: (2009) -
Noradrenergic symptom cluster in depression
by: Montgomery S, et al.
Published: (2011) -
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
by: Kamijima K, et al.
Published: (2013)